Title: Medical Supplies for Pandemics Act of 2020
Policy area: Health

Summary:
Medical Supplies for Pandemics Act of 2020
This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies. Specifically, HHS must (1) create incentives for manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture.
The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2023.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 3827 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  2d Session
                                S. 3827

  To amend the Public Health Service Act to authorize the use of the 
Strategic National Stockpile to enhance medical supply chain elasticity 
   and establish and maintain domestic reserves of critical medical 
                   supplies, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 21, 2020

 Mr. Tillis (for himself, Mr. Bennet, and Mrs. Hyde-Smith) introduced 
the following bill; which was read twice and referred to the Committee 
               on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
  To amend the Public Health Service Act to authorize the use of the 
Strategic National Stockpile to enhance medical supply chain elasticity 
   and establish and maintain domestic reserves of critical medical 
                   supplies, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medical Supplies for Pandemics Act 
of 2020''.

SEC. 2. SUPPLY CHAIN FLEXIBILITY MANUFACTURING PILOT.

    (a) In General.--Section 319F-2(a)(3) of the Public Health Service 
Act (42 U.S.C. 247d-6b(a)(3)) is amended--
            (1) in subparagraph (I), by striking ``and'' at the end;
            (2) in subparagraph (J), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following new subparagraph:
                    ``(K) enhance medical supply chain elasticity and 
                establish and maintain domestic reserves of critical 
                medical supplies (including personal protective 
                equipment, ancillary medical supplies, and other 
                applicable supplies required for the administration of 
                drugs, vaccines and other biological products, medical 
                devices, and diagnostic tests) by--
                            ``(i) creating incentives for manufacturers 
                        of medical supplies--
                                    ``(I) to increase emergency stock 
                                of critical medical supplies; and
                                    ``(II) to geographically diversify 
                                production of such supplies;
                            ``(ii) purchasing, leasing, or entering 
                        into joint ventures with respect to, facilities 
                        and equipment for the production of medical 
                        supplies; and
                            ``(iii) working with distributors of 
                        medical supplies to manage the domestic 
                        reserves established under this subparagraph by 
                        refreshing and replenishing stock of critical 
                        medical supplies.''.
    (b) Reporting; Sunset.--Section 319F-2(a) of the Public Health 
Service Act (42 U.S.C. 247d-6b(f)) is amended by adding at the end the 
following:
            ``(6) Reporting.--Not later than September 30, 2022, the 
        Secretary shall submit to the Committee on Energy and Commerce 
        of the House of Representatives and the Committee on Health, 
        Education, Labor, and Pensions of the Senate a report on the 
        details of each purchase, lease, or joint venture entered into 
        under paragraph (3)(K), including the amount expended by the 
        Secretary on each such purchase, lease, or joint venture.
            ``(7) Sunset.--The authority to make purchases, leases, or 
        joint ventures pursuant to paragraph (3)(K) shall cease to be 
        effective on September 30, 2023.''.
    (c) Funding.--Section 319F-2(f) of the Public Health Service Act 
(42 U.S.C. 247d-6b(f)) is amended by adding at the end the following:
            ``(3) Supply chain elasticity.--
                    ``(A) In general.--For the purpose of carrying out 
                subsection (a)(3)(K), there is authorized to be 
                appropriated $500,000,000 for each of fiscal years 2020 
                through 2023, to remain available until expended.
                    ``(B) Relation to other amounts.--The amount 
                authorized to be appropriated by subparagraph (A) for 
                the purpose of carrying out subsection (a)(3)(K) is in 
                addition to any other amounts available for such 
                purpose.''.
                                 <all>